Genenta Science (GNTA) Institutional Ownership $2.99 +0.05 (+1.70%) As of 10:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Genenta Science (NASDAQ:GNTA)CurrentInstitutional OwnershipPercentage15.13%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.22MNumber ofInstitutional Sellers(last 12 months)0 Get GNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Genenta Science stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data GNTA Institutional Buying and Selling by Quarter Genenta Science Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/9/2025Allianz SE233,550$927K0.0%+126.2%1.277% 5/8/2025Algebris UK Ltd100,000$368K0.1%+122.2%0.547% 2/17/2025Citadel Advisors LLC11,167$46K0.0%N/A0.061% 2/12/2025Allianz SE103,250$444K0.0%N/A0.565% 8/15/2024AlTi Global Inc.200,288$621K0.0%N/A1.099% 7/24/2023Bank Julius Baer & Co. Ltd Zurich412,547$2.46M0.0%N/A2.264% 7/20/2023Bank Julius Baer & Co. Ltd Zurich412,547$2.46M0.0%N/A2.264% 2/13/2023Algebris UK Ltd45,000$242K0.1%N/A0.247% (Data available from 1/1/2016 forward) GNTA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GNTA shares? During the previous two years, the following institutional investors and hedge funds held shares of Genenta Science shares: Allianz SE ($927K), AlTi Global Inc. ($621K), and Algebris UK Ltd ($368K), Citadel Advisors LLC ($46K).Learn more on Genenta Science's institutional investors. What percentage of Genenta Science's stock is owned by institutional investors? 15.13% of Genenta Science's stock is owned by institutional investors. Learn more on GNTA's institutional investor holdings. Which institutional investors have been buying Genenta Science's stock? The following institutional investors have purchased Genenta Science's stock in the last 24 months: Allianz SE ($233.55K), AlTi Global Inc. ($200.29K), Algebris UK Ltd ($55K), and Citadel Advisors LLC ($11.17K). How much institutional buying is happening at Genenta Science? Institutional investors have bought a total of 299,717 shares in the last 24 months. This purchase volume represents approximately $1.22M in transactions. Related Companies Aardvark Therapeutics Institutional Ownership SOPHiA GENETICS Institutional Ownership CARGO Therapeutics Institutional Ownership GENFIT Institutional Ownership Aerovate Therapeutics Institutional Ownership Sagimet Biosciences Institutional Ownership ProQR Therapeutics Institutional Ownership Aclaris Therapeutics Institutional Ownership Tenaya Therapeutics Institutional Ownership Tiziana Life Sciences Institutional Ownership This page (NASDAQ:GNTA) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genenta Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.